Author
Z. Lv
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2018-2023 · peak 7/yrCo-Author Collaboration Network
10 top collaborators · 32 mutual co-author links19 papers
Recent·Most cited
O-GlcNAcylation of YTHDF2 antagonizes ERK-dependent phosphorylation and inhibits lung carcinoma
J. Li, W. Zhou, J. Zhang, L. Ma, Z. Lv, Y. Geng, X. Chen, J. Li
This study identifies O-GlcNAcylation of YTHDF2 at Thr-49 as a regulator of ERK-dependent phosphorylation and tumor growth in lung carcinoma.
bioRxiv · Sep 9, 2023Biochemistry
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
A. Yisimayi, W. Song, J. Wang, F. Jian, Y. Yu, X. Chen, Y. Xu, S. Yang, X. Niu, T. Xiao, J. Wang, L. Zhao, H. Sun, R. An, N. Zhang, , Y. Cao
This study shows repeated Omicron exposures reduce immune imprinting from wildtype vaccines, leading to higher neutralizing antibodies against XBB variants.
bioRxiv · May 1, 2023Immunology
Airway secretory cell-derived p63+ progenitors contribute to alveolar regeneration after sterile lung injury
Z. Lv, Z. Liu, K. Liu, W. Pu, Y. Li, H. Zhao, Y. Xi, A. Vaughan, A. Gillich, B. Zhou
bioRxiv · Feb 27, 2023 · PreprintCell Biology
Host-microbe interactions mediate doramectin-promoted metabolic reprogramming of CD8+ T-cells and amplify antitumor immunity
S. Taghinezhad-S, A. H. Mohseni, W. Jiang, V. Casolaro, L. G. Bermudez-Humaran, F. McAllister, Z. Lv, D. Li
This study shows that doramectin promotes CD8+ T-cell metabolic reprogramming and antitumor immunity, mediated by gut microbiota interactions.
bioRxiv · Jan 29, 2023 · PreprintCancer Biology
Cryo-EM complex structure of active GPR75 with a nanobody
Z. Lv, Y. He, Y. Xiang, J. Li, F. Meng, H. Zhao, H. Guo, D. He, Y. Wang, W. Zhuo, Y. Liu, X. Ni, J. Heng
The paper reports the Cryo-EM structure of active GPR75 with a nanobody, revealing its activation mechanism and providing a structural basis for anti-obesity drug discovery.
bioRxiv · Aug 18, 2022 · PreprintBiophysics
Development of Equine Polyclonal Antibodies as a Broad-Spectrum Therapy Against SARS-CoV-2 Variants
S. Liao, Y. He, J. Qu, Y. Shi, Y. Liu, K. Zhao, J. Chen, Y. Jing, C. K.-F. Shen, C. Ji, G. Luo, X. Zhao, S. Li, Y. Fan, Z. Lv, , L. Li
This paper develops equine polyclonal antibodies that broadly neutralize major SARS-CoV-2 variants, showing high efficacy in vitro and ex vivo with low cost and potential for large-scale production.
bioRxiv · Jul 27, 2022 · PreprintImmunology
Screening of cell-virus, cell-cell, gene-gene interactions among kingdoms of life at single cell resolution
D. Chen, Z. Ou, J. Zhu, P. Ding, H. Wang, L. Luo, X. Ding, T. Lan, W. Wu, Y. Yuan, W. Wu, J. Qiu, Y. Zhu, Y. Jia, Y. Wei, , H. Liu
The paper screens cell-virus and cell-cell interactions across multiple species to identify potential hosts and co-evolution patterns of viruses including SARS-CoV-2.
bioRxiv · Aug 13, 2021 · PreprintCell Biology
Viral receptor profiles of masked palm civet revealed by single-cell transcriptomics
D. Chen, Z. Ou, H. Wang, Y. Zhang, J. Zhu, F. An, J. Xu, X. Ding, P. Ding, L. Luo, W. Wu, Q. Qin, Y. Wei, W. Zhao, Z. Lv, , Y. Hua
The paper uses single-cell transcriptomics to profile viral receptor expression in masked palm civets, identifying potential tissue tropisms for 132 viruses.
bioRxiv · Jul 20, 2021 · PreprintImmunology
ICER controls HIV-1 infection and replication in elite controllers
Z. Luo, M. Li, T. Li, Z. Lv, Z. Ye, W. J. Cisneros, J. Zhang, L. Yuan, J. F. Hultquist, S. Migueles, J. Zhu, W. Jiang
The paper identifies ICER as a host factor that contributes to HIV resistance in elite controllers by regulating HIV-1 replication through alternative splicing and promoter activity.
bioRxiv · Jun 30, 2021 · PreprintImmunology
Double Lock of a Potent Human Monoclonal Antibody against SARS-CoV-2
X. Wang, C. Qin, Y. Wang, Z. Rao, L. Xie, L. Zhu, Y.-Q. Deng, R.-r. Zhang, Z. Cui, C.-Y. Sun, C.-F. Fan, X. Xing, W. Huang, Q. Chen, N.-N. Zhang, , J. Hu
This paper identifies and characterizes a potent human monoclonal antibody, HB27, that blocks SARS-CoV-2 receptor binding and membrane fusion, showing protective effects in mice and non-adverse effects in rhesus macaques.
bioRxiv · Nov 24, 2020 · PreprintBiophysics
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Z. Lv, Y.-Q. Deng, Q. Ye, L. Cao, C.-Y. Sun, C. Fan, W. Huang, S. Sun, Y. Sun, L. Zhu, Q. Chen, N. Wang, J. Nie, Z. Cui, D. Zhu, , X. Wang
A potent neutralizing antibody protected against SARS-CoV-2 in an hACE2 mouse model by blocking viral receptor interaction.
Science · Sep 18, 2020Peer-reviewedBiophysics
Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases - PLpro and Mpro in in vitro studies
M. Zmudzinski, W. Rut, K. Olech, J. Granda, M. Giurg, M. Burda-Grabowska, L. Zhang, X. Sun, Z. Lv, D. Nayak, M. Kesik-Brodacka, S. Olsen, R. Hilgenfeld, M. Drag
This study identifies ebselen derivatives as potent inhibitors of SARS-CoV-2 proteases PLpro and Mpro in vitro, with some compounds showing greater potency than ebselen itself.
bioRxiv · Aug 30, 2020 · PreprintBiochemistry
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design
W. Rut, Z. Lv, M. Zmudzinski, S. Patchett, D. Nayak, S. J. Snipas, F. El Oualid, M. Bekes, T. T. Huang, M. Drag, S. K. Olsen
This study profiles SARS-CoV-2-PLpro activity and determines inhibitor structures to guide anti-COVID-19 drug design.
bioRxiv · Apr 29, 2020 · PreprintBiochemistry
Rapid development of an inactivated vaccine for SARS-CoV-2
Q. Gao, L. Bao, H. Mao, L. Wang, K. Xu, m. Yang, Y. Li, L. Zhu, N. Wang, Z. Lv, H. Gao, X. Ge, B. Kan, Y. Hu, J. Liu, , C. Qin
A purified inactivated SARS-CoV-2 vaccine candidate (PiCoVacc) induces neutralizing antibodies in animals and shows safety and partial to complete protection against SARS-CoV-2 strains.
bioRxiv · Apr 17, 2020Microbiology
Plastome phylogenomic study of Gentianeae (Gentianaceae): widespread gene tree discordance and its association with evolutionary rate heterogeneity of plastid genes
X. Zhang, Y. Sun, J. B. Landis, Z. Lv, J. Shen, H. Zhang, N. Lin, L. Li, J. Sun, T. Deng, H. Sun, H. Wang
This study analyzes plastome sequences from Gentianeae to show gene tree discordance and evolutionary rate heterogeneity among plastid genes, suggesting the need for more nuanced phylogenomic approaches.
bioRxiv · Apr 2, 2020Evolutionary Biology
Exfoliated near infrared fluorescent CaCuSi4O10 nanosheets with ultra-high photostability and brightness for biological imaging
G. Selvaggio, H. Preiss, A. Chizhik, R. Nissler, F. Mann, Z. Lv, T. Oswald, A. Spreinat, L. Erpenbeck, J. Grosshans, J. P. Giraldo, S. Kruss
This paper develops exfoliated CaCuSi4O10 nanosheets with ultra-high near infrared fluorescence for biological imaging in animals and plants.
Nature Communications · Mar 20, 2020Peer-reviewedBiophysics
Spontaneous Self-assembly of Amyloid β (1-40) into Dimers
M. Hashemi, Y. Zhang, Z. Lv, Y. L. Lyubchenko
This study uses molecular dynamics simulations to show that Aβ(1-40) monomers form stable dimers through specific inter-peptide interactions, without forming long β-strands typical of fibrils.
bioRxiv · Jun 4, 2019Biophysics
KPNA2 promotes cellular proliferation and inhibits apoptosis in the Saos-2 osteosarcoma cell line
D. Wei, Q. Ge, X. Sun, L. Zhang, J. Li, C. Chen, z. lv, Dinglu WeiQiaofeng GeXiaojuan SunLong ZhangJia LiChenglong ChenZhi Lv
This study shows KPNA2 is highly expressed in osteosarcoma tissues and its reduction inhibits cell proliferation and promotes apoptosis in Saos-2 cells.
bioRxiv · Oct 5, 2018 · PreprintCancer Biology